Immunogenicity of Extended mRNA SARS-CoV-2 Vaccine Dosing Intervals
- PMID: 34860253
- PMCID: PMC8642809
- DOI: 10.1001/jama.2021.21921
Immunogenicity of Extended mRNA SARS-CoV-2 Vaccine Dosing Intervals
Abstract
This study investigates the immunogenicity of extended mRNA vaccine dosing intervals.
Conflict of interest statement
Figures
References
-
- Centers for Disease Control and Prevention (CDC) . COVID-19. Accessed August 11, 2021. https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-v...
-
- Voysey M, Costa Clemens SA, Madhi SA, et al. ; Oxford COVID Vaccine Trial Group . Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet. 2021;397(10277):881-891. doi:10.1016/S0140-6736(21)00432-3 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Miscellaneous
